Olema Pharmaceuticals (OLMA) Treasury Shares (2020 - 2026)
Olema Pharmaceuticals (OLMA) reported Treasury Shares of $402807.0 for Q1 2026, little changed quarter-over-quarter from $403000.0 in Q2 2024.
Olema Pharmaceuticals (OLMA) Treasury Shares (2020 - 2026) Analysis & Trends
Olema Pharmaceuticals (OLMA) has 6 years of Treasury Shares data on file, last reported at $402807.0 in Q1 2026.
- Treasury Shares for Q1 2026 came in at $402807.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $402807.0 (changed N/A YoY), and the FY2023 annual result was $92659.0, down 86.95% from the prior year.
- Treasury Shares steadied at $402807.0 in Q1 2026 per OLMA's latest filing, from $403000.0 in the prior quarter.
- Over five years, Treasury Shares peaked at $710000.0 in Q4 2022 and troughed at $40352.0 in Q1 2024.
- A 4-year average of $311298.7 and a median of $345230.0 in 2022 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2023 and 2024: Treasury Shares slumped 86.95% in 2023, then jumped 104.28% in 2024.
- A 4-year view of Treasury Shares shows it stood at $710000.0 in 2022, then tumbled by 86.95% to $92659.0 in 2023, then soared by 334.93% to $403000.0 in 2024, then dropped by 0.05% to $402807.0 in 2026.
- Business Quant data shows OLMA's Treasury Shares at $402807.0 in Q1 2026, $403000.0 in Q2 2024, and $40352.0 in Q1 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Olema Pharmaceuticals | 1.01 Bn | 1.01 Bn | - | 402,807.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 402,807.00 |
| Mar 31, 2026 | 402,807.00 |
| Jun 30, 2024 | 403,000.00 |
| Jun 30, 2024 | 403,000.00 |
| Mar 31, 2024 | 40,352.00 |
| Mar 31, 2024 | 40,352.00 |
| Dec 31, 2023 | 92,659.00 |
| Dec 31, 2023 | 92,659.00 |
| Sep 30, 2023 | 147,956.00 |
| Sep 30, 2023 | 147,956.00 |
| Jun 30, 2023 | 197,274.00 |
| Jun 30, 2023 | 197,274.00 |
| Mar 31, 2023 | 246,593.00 |
| Mar 31, 2023 | 246,593.00 |
| Dec 31, 2022 | 710,000.00 |
| Dec 31, 2022 | 710,000.00 |
| Sep 30, 2022 | 345,230.00 |
| Sep 30, 2022 | 345,230.00 |
| Jun 30, 2022 | 394,548.00 |
| Jun 30, 2022 | 394,548.00 |